| Identification | Back Directory | [Name]
1H-Imidazo[4,5-c]quinoline-1-butanamine, 4-amino-2-ethyl- | [CAS]
313350-30-0 | [Synonyms]
AXC-666
1H-Imidazo[4,5-c]quinoline-1-butanamine, 4-amino-2-ethyl-
1-(4-aminobutyl)-2-ethyl-1H-imidazo[4,5-c]quinolin-4-amine | [Molecular Formula]
C16H21N5 | [MOL File]
313350-30-0.mol | [Molecular Weight]
283.37 |
| Chemical Properties | Back Directory | [Boiling point ]
542.2±40.0 °C(Predicted) | [density ]
1.30±0.1 g/cm3(Predicted) | [form ]
Solid | [pka]
10.36±0.10(Predicted) | [color ]
Off-white to light yellow |
| Hazard Information | Back Directory | [Uses]
AXC-666, an immune agonist, is a Imiquimod (HY-B0180) derivative. AXC-666 can be used for the synthesis of antibody-drug conjugate (ADC)[1]. | [References]
[1] Moon SJ, et, al. Compositions containing, methods and uses of antibody-tlr agonist conjugates. WO2020168017. |
|
| Company Name: |
Biorbyt Ltd.
|
| Tel: |
+44 (0)1223 859 353 |
| Website: |
http://www.biorbyt.com |
|